Hormone therapy in Fanconi anemia

Bibliography

• Fanconi Anemia: Guidelines for Diagnosis and Management. In: Hays L, Frohnmayer D, Frohnmayer L, Guinan E, Kennedy T, 4th Edition. Fanconi Anemia Research Fund, Inc, Eugene, 2014. Available from: http://fanconi.org
   Google Scholar
• Shimamura A, Alter BP. Pathophysiology and management of inherited bone marrow failure syndromes. Blood Rev 2010;24(3):101-22
   PubMed Web of Science ®Google Scholar
• Parikh S, Bessler M. Recent insights into inherited bone marrow failure syndromes. Curr Opin Pediatr 2012;24(1):23-32
   Google Scholar
• Petryk A, Kanakatti Shankar R, et al. Endocrine disorders in Fanconi anemia: recommendations for screening and treatment. J Clin Endocrinol Metab 2015;100(3):803-11
   PubMed Web of Science ®Google Scholar
• Rose SR, Myers KC, Rutter MM, et al. Endocrine phenotype of children and adults with Fanconi anemia. Pediatr Blood Cancer 2012;59(4):690-6
   PubMed Web of Science ®Google Scholar
• Li J, Sipple J, Maynard S, et al. Fanconi anemia links reactive oxygen species to insulin resistance and obesity. Antioxid Redox Signal 2012;17(8):1083-98
   PubMed Web of Science ®Google Scholar
• Pagano G, Youssoufian H. Fanconi anaemia proteins: major roles in cell protection against oxidative damage. Bioessays 2003;25(6):589-95
   Google Scholar
• Wajnrajch MP, Gertner JM, Huma Z, et al. Evaluation of growth and hormonal status in patients referred to the International Fanconi Anemia Registry. Pediatrics 2001;107(4):744-54
   Google Scholar
• Rose SR. Improved diagnosis of mild hypothyroidism using time-of-day normal ranges for thyrotropin. J Pediatr 2010;157(4):662-7
   Google Scholar
• Eyal O, Blum S, Mueller R, et al. Improved growth velocity during thyroid hormone therapy in children with Fanconi anemia and borderline thyroid function. Pediatr Blood Cancer 2008;51(5):652-6
   Google Scholar
• Cook DM, Rose SR. A review of guidelines for use of growth hormone in pediatric and transition patients. Pituitary 2012;15(3):301-10
   PubMed Web of Science ®Google Scholar
• Wilson TA, Rose SR, Cohen P, et al. Update of guidelines for the use of growth hormone in children: the Lawson Wilkins Pediatric Endocrinology Society Drug and Therapeutics Committee. J Pediatr 2003;143(4):415-21
   PubMed Web of Science ®Google Scholar
• Forlenza GP, Polgreen LE, Miller BS, et al. Growth hormone treatment of patients with Fanconi anemia after hematopoietic cell transplantation. Pediatr Blood Cancer 2014;61(6):1142-3
   PubMed Web of Science ®Google Scholar
• Kemp SF, Kuntze J, Attie KM, et al. Efficacy and safety results of long-term growth hormone treatment of idiopathic short stature. J Clin Endocrinol Metab 2005;90(9):5247-53
   Google Scholar
• Quigley CA, Gill AM, Crowe BJ, et al. Safety of growth hormone treatment in pediatric patients with idiopathic short stature. J Clin Endocrinol Metab 2005;90(9):5188-96
   Google Scholar
• Patterson BC, Chen Y, Sklar CA, et al. Growth hormone exposure as a risk factor for the development of subsequent neoplasms of the central nervous system: a report from the childhood cancer survivor study. J Clin Endocrinol Metab 2014;99(6):2030-7
   PubMedGoogle Scholar
• Pekic S, Popovic V. GH therapy and cancer risk in hypopituitarism: What we know from human studies. Eur J Endocrinol 2013;169(5):R89-97
   Google Scholar
• Hartman ML, Xu R, Crowe BJ, et al. Prospective safety surveillance of GH-deficient adults: comparison of GH-treated vs untreated patients. J Clin Endocrinol Metab 2013;98(3):980-8
   PubMedGoogle Scholar
• Mackenzie S, Craven T, Gattamaneni HR, et al. Long-term safety of growth hormone replacement after CNS irradiation. J Clin Endocrinol Metab 2011;96(9):2756-61
   PubMedGoogle Scholar
• Bell J, Parker KL, Swinford RD, et al. Long-term safety of recombinant human growth hormone in children. J Clin Endocrinol Metab 2010;95(1):167-77
   PubMed Web of Science ®Google Scholar
• Longmore DK, Conwell LS, Burke JR, et al. Post-transplant lymphoproliferative disorder: no relationship to recombinant human growth hormone use in Australian and New Zealand pediatric kidney transplant recipients. Pediatr Transplant 2013;17(8):731-6
   Google Scholar
• Poidvin A, Touzé E, Ecosse E, et al. Growth hormone treatment for childhood short stature and risk of stroke in early adulthood. Neurol 2014;83(9):780-6
   Google Scholar
• Carel JC, Ecosse E, Landier F, et al. Long-term mortality after recombinant growth hormone treatment for isolated growth hormone deficiency or childhood short stature: Preliminary report of the French SAGhE study. J Clin Endocrinol Metab 2012;97(2):416-25
   PubMedGoogle Scholar
• Erfurth EM. Update in mortality in GH-treated patients. J Clin Endocrinol Metab 2013;98(11):4219-26
   PubMedGoogle Scholar
• Sävendahl L, Maes M, Albertsson-Wikland K, et al. Long-term mortality and causes of death in isolated GHD, ISS, and SGA patients treated with recombinant growth hormone during childhood in Belgium, The Netherlands, and Sweden: Preliminary report of 3 countries participating in the EU SAGhE study. J Clin Endocrinol Metab 2012;97(2):E213-17
   Google Scholar
• van Bunderen CC, van Varsseveld NC, Erfurth EM, et al. Efficacy and safety of growth hormone treatment in adults with growth hormone deficiency: A systematic review of studies on morbidity. Clin Endocrinol (Oxf) 2014;81(1):1-14
   Google Scholar
• Hindmarsh PC, Peters CJ. Growth hormone treatment and stroke: Should we be concerned? A case for cohort studies. Clin Endocrinol (Oxf) 2014; [Epub ahead of print]
   Google Scholar
• Malozowski S. Reports of increased mortality and GH: Will this affect current clinical practice? J Clin Endocrinol Metab 2012;97(2):380-3
   Google Scholar
• Ichord RN. Adult stroke risk after growth hormone treatment in childhood: First do no harm. Neurol 2014;83(9):776-7
   Google Scholar
• Spencer D. Long-term risk of stroke in children treated with growth hormone for short stature: Looking at the big picture. Neurol 2014;83(9):e103-5
   Google Scholar
• Nunez SB, Municchi G, Barnes KM, Rose SR. Insulin-like growth factor-1 (IGF-I) and IGF-binding protein-3 concentrations compared to stimulated and night growth hormone in the evaluation of short children: A clinical research center study. J Clin Endocrinol Metab 1996;81(5):1927-32
   Google Scholar
• Martinez AS, Domene HM, Ropelato MG, et al. Estrogen priming effect on growth hormone (GH) provocative test: A useful tool for the diagnosis of GH deficiency. J Clin Endocrinol Metab 2000;85(11):4168-72
   Google Scholar
• Petryk A, Baker KS, Frohnert B, et al. Blunted response to a growth hormone stimulation test is associated with unfavorable cardiovascular risk factor profile in childhood cancer survivors. Pediatr Blood Cancer 2013;60(3):467-73
   Google Scholar
• Kargi AY, Merriam GR. Testing for growth hormone deficiency in adults: doing without growth hormone-releasing hormone. Curr Opinion Endocrinol Diabetes Obes 2012;19(4):300-5
   Google Scholar
• Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. J Clin Endocrinol Metab 2000;85(11):3990-3
   PubMed Web of Science ®Google Scholar
• Sherafat-Kazemzadeh R, Mehta SN, Care MM, et al. Small pituitary size in children with Fanconi anemia. Pediatr Blood Cancer 2007;49(2):166-70
   Google Scholar
• Aynsley-Green A, Zachmann M, Werder EA, et al. Endocrine studies in Fanconi’s anaemia. Report of 4 cases. Arch Dis Child 1978;53(2):126-31
   Google Scholar
• Giri N, Batista DL, Alter BP, Stratakis CA. Endocrine abnormalities in patients with Fanconi anemia. J Clin Endocrinol Metab 2007;92(7):2624-31
   PubMed Web of Science ®Google Scholar
• Lenzen S, Drinkgern J, Tiedge M. Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. Free Rad Biol Med 1996;20(3):463-6
   PubMed Web of Science ®Google Scholar
• Sigfrid LA, Cunningham JM, Beeharry N, et al. Antioxidant enzyme activity and mRNA expression in the islets of Langerhans from the BB/S rat model of type 1 diabetes and an insulin-producing cell line. J Mol Med (Berl) 2004;82(5):325-35
   Google Scholar
• Yanovski JA, Rose SR, Municchi G, et al. Treatment with a luteinizing hormone-releasing hormone agonist in adolescents with short stature. N Engl J Med 2003;348(10):908-17
   PubMed Web of Science ®Google Scholar
• Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011;96(7):1911-30
   PubMed Web of Science ®Google Scholar
• Dvorak CC, Gracia CR, Sanders JE, et al. NCI, NHLBI/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation: endocrine challenges-thyroid dysfunction, growth impairment, bone health, & reproductive risks. Biol Blood Marrow Transplant 2011;17:1725-38
   PubMed Web of Science ®Google Scholar
• Ward L, Tricco AC, Phuong P, et al. Bisphosphonate therapy for children and adolescents with secondary osteoporosis. Cochrane Database Syst Rev 2007;CD005324
   Google Scholar
• Baim S, Leonard MB, Bianchi ML, et al. Official positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Pediatric Position Development Conference. J Clin Densitom 2008;11(1):6-21
   Google Scholar
• Gordon CM, Bachrach LK, Carpenter TO, et al. Dual energy X-ray absorptiometry interpretation and reporting in children and adolescents: The 2007 ISCD Pediatric Official Positions. J Clin Densitom 2008;11(1):43-58
   PubMed Web of Science ®Google Scholar
• Ward LM, Petryk A, Gordon CM. Use of bisphosphonates in the treatment of pediatric osteoporosis. Int J Clin Rheumatol 2009;4:657-72
   Google Scholar
• Pulsipher MA, Skinner R, McDonald GB, et al. National cancer institute, national heart, lung and blood institute/pediatric blood and marrow transplantation consortium first international consensus conference on late effects after pediatric hematopoietic cell transplantation: The need for pediatric-specific long-term follow-up guidelines. Biol Blood Marrow Transplant 2012;18(3):334-47
   Google Scholar
• Available from: http://www.bmdcspublic.com/zscore.htm
   Google Scholar
• Swift M. Fanconi’s anaemia in the genetics of neoplasia. Nature 1971;230(5293):370-3
   Google Scholar
• Auerbach AD, Allen RG. Leukemia and preleukemia in fanconi anemia patients. a review of the literature and report of the international fanconi anemia registry. Cancer Genet Cytogenet 1991;51(1):1-12
   Google Scholar
• Butturini A, Gale RP, Verlander PC, et al. Hematologic abnormalities in fanconi anemia: an international fanconi anemia registry study. Blood 1994;84(5):1650-5
   PubMed Web of Science ®Google Scholar